Results 111 to 120 of about 1,471,327 (421)

Rheumatoid arthritis [PDF]

, 2016
Rheumatoid arthritis is a chronic inflammatory joint disease, which can cause cartilage and bone damage as well as disability. Early diagnosis is key to optimal therapeutic success, particularly in patients with well-characterised risk factors for poor ...
Aletaha, Daniel, McInnes, Iain B., Smolen, Josef S.   +2 more
core   +1 more source

Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?

Therapeutic Advances in Hematology, 2020
Background: Posaconazole prophylaxis during remission induction chemotherapy not only decreases the incidence of invasive aspergillosis (IA) but also improves the overall survival rate among patients with acute myeloid leukemia (AML). However, it remains
Tsung-Chih Chen, Ren Ching Wang, Yu-Hui Lin, Kuang-Hsi Chang, Li-Ya Hung, Chieh-Lin Jerry Teng   +5 more
doaj   +1 more source

Efficacy and safety of medical therapies in microscopic colitis: a systematic review and network meta-analysis

Therapeutic Advances in Gastroenterology, 2023
Background: The mainstay of treatment for microscopic colitis (MC) is budesonide. However, the optimal formulation and dosage of budesonide to induce and maintain remission has not yet been clearly demonstrated.
Aditi Kumar, George Hiner, Matthew J. Brookes, Jonathan P. Segal   +3 more
doaj   +1 more source

Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. [PDF]

, 2015
Takayasu arteritis (TA) is an idiopathic large-vessel vasculitis affecting the aorta and its major branches. Although the disease rarely affects children, it does occur, even in infants.
Al-Obaidi, M, Brogan, PA, Dolezalova, P, Eleftheriou, D, McMahon, AM, Varnier, G   +5 more
core   +1 more source

Perioperative optimization of Crohn's disease

Annals of Gastroenterological Surgery, Volume 7, Issue 1, Page 10-26, January 2023., 2023
Most Crohn's disease patients require surgery during the course of their illness, especially those who experience complications. The management of perioperative medications and surgery‐related decision‐making should be individualized and patient‐centered based on a multidisciplinary approach.
Chun‐Chi Lin, Hung‐Hsin Lin, Hui‐Chuen Chen, Nai‐Chia Chen, I‐Lun Shih, Ji‐Shiang Hung, Te‐Cheng Yueh, Feng‐Fan Chiang, Ping‐Wei Lin, Yuan‐Yao Tsai, Shu‐Chen Wei   +10 more
wiley   +1 more source

Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis

Indian Journal of Rheumatology, 2019
The prognosis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has remarkably improved from an almost uniformly fatal disease about three decades back, to a chronic manageable disease with survival rates in excess of 80 ...
Durga Prasanna Misra, G SRSN K Naidu, Aman Sharma   +2 more
doaj   +1 more source

Acute Heart Failure Is a Malignant Process: But We Can Induce Remission

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Acute heart failure is a common and increasingly prevalent condition, affecting >10 million people annually. For those patients who survive to discharge, early readmissions and death rates are >30% everywhere on the planet, making it a malignant ...
Gad Cotter, Beth A. Davison, Carolyn S. P. Lam, Marco Metra, Piotr Ponikowski, John R. Teerlink, Alexandre Mebazaa   +6 more
doaj   +1 more source

Certolizumab pegol for induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews, 2017
Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract, and immune response modulation is the main treatment strategy to induce remission in active CD. Certolizumab pegol (CZP) is a tumor necrosis factor-alfa (TNF-α) inhibitor which regulates impaired immune response.The primary objectives were to evaluate the efficacy and
Yasushi Tsujimoto, Minoru Matsuura, Toshi A. Furukawa, Ryuhei So, Norio Watanabe, Shinichiro Shinzaki, Taku Kobayashi, Shinji Okabayashi, Katsuyoshi Matsuoka, Yuki Kataoka, Hajime Yamazaki   +10 more
openaire   +5 more sources

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy. [PDF]

, 2019
Introduction: Acute myeloid leukemia (AML) remains a disease with high mortality, especially for older patients and those with relapsed/refractory (R/R) disease.
Galkin, Maria, Jonas, Brian A
core   +1 more source

Claustrum Volume Is Reduced in Multiple Sclerosis and Predicts Disability

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The claustrum is a small, thin structure of predominantly gray matter with broad connectivity and enigmatic function. Little is known regarding the impact of claustrum pathology in multiple sclerosis (MS). Methods This study assessed whether claustrum volume was reduced in MS and whether reductions were associated with specific ...
Nicole Shelley, Bradley Judge, Dmitriy A. Yablonskiy, Robert T. Naismith, Matthew R. Brier, Anne H. Cross   +5 more
wiley   +1 more source